139 related articles for article (PubMed ID: 9148412)
1. New vaccines may ward off urinary tract infections.
Service RF
Science; 1997 Apr; 276(5312):533. PubMed ID: 9148412
[No Abstract] [Full Text] [Related]
2. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.
Langermann S; Möllby R; Burlein JE; Palaszynski SR; Auguste CG; DeFusco A; Strouse R; Schenerman MA; Hultgren SJ; Pinkner JS; Winberg J; Guldevall L; Söderhäll M; Ishikawa K; Normark S; Koenig S
J Infect Dis; 2000 Feb; 181(2):774-8. PubMed ID: 10669375
[TBL] [Abstract][Full Text] [Related]
3. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
Langermann S; Palaszynski S; Barnhart M; Auguste G; Pinkner JS; Burlein J; Barren P; Koenig S; Leath S; Jones CH; Hultgren SJ
Science; 1997 Apr; 276(5312):607-11. PubMed ID: 9110982
[TBL] [Abstract][Full Text] [Related]
4. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections.
Langermann S; Ballou WR
J Infect Dis; 2001 Mar; 183 Suppl 1():S84-6. PubMed ID: 11171023
[No Abstract] [Full Text] [Related]
5. Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis.
Habibi M; Asadi Karam MR; Bouzari S
APMIS; 2016 Jun; 124(6):444-52. PubMed ID: 26918627
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.
Asadi Karam MR; Oloomi M; Mahdavi M; Habibi M; Bouzari S
Vaccine; 2013 Feb; 31(8):1210-6. PubMed ID: 23306365
[TBL] [Abstract][Full Text] [Related]
7. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response.
Verdonck F; Cox E; Van der Stede Y; Goddeeris BM
Vaccine; 2004 Oct; 22(31-32):4291-9. PubMed ID: 15474721
[TBL] [Abstract][Full Text] [Related]
8. [Antibody response in mice, rabbits and pigs in response to vaccination with an inactivated oil vaccine containing rotavirus and Escherichia coli strains with K88, K99 and 987P fimbrial antigens].
Zuffa A; Salajka E; Zajac J; Salajková Z; Zuffa T; Alexa P
Vet Med (Praha); 1991 Jul; 36(7):423-31. PubMed ID: 1686823
[TBL] [Abstract][Full Text] [Related]
9. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis.
Habibi M; Asadi Karam MR; Shokrgozar MA; Oloomi M; Jafari A; Bouzari S
Mol Immunol; 2015 Apr; 64(2):285-94. PubMed ID: 25562574
[TBL] [Abstract][Full Text] [Related]
10. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.
Thankavel K; Madison B; Ikeda T; Malaviya R; Shah AH; Arumugam PM; Abraham SN
J Clin Invest; 1997 Sep; 100(5):1123-36. PubMed ID: 9276729
[TBL] [Abstract][Full Text] [Related]
11. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.
Palaszynski S; Pinkner J; Leath S; Barren P; Auguste CG; Burlein J; Hultgren S; Langermann S
Dev Biol Stand; 1998; 92():117-22. PubMed ID: 9554264
[TBL] [Abstract][Full Text] [Related]
12. The antibody response in infants after oral administration of inactivated and living E. coli vaccines and their protective effect against nosocomial infections.
Lodinová-Zádníková R; Tlaskalová H; Korych B; Bartáková Z
Adv Exp Med Biol; 1995; 371B():1431-8. PubMed ID: 7502832
[No Abstract] [Full Text] [Related]
13. FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections.
Nesta B; Spraggon G; Alteri C; Moriel DG; Rosini R; Veggi D; Smith S; Bertoldi I; Pastorello I; Ferlenghi I; Fontana MR; Frankel G; Mobley HL; Rappuoli R; Pizza M; Serino L; Soriani M
mBio; 2012; 3(2):. PubMed ID: 22496310
[TBL] [Abstract][Full Text] [Related]
14. Development of a recombinant FimCH vaccine for urinary tract infections.
Langermann S; Ballou WR
Adv Exp Med Biol; 2003; 539(Pt B):635-48. PubMed ID: 15176317
[No Abstract] [Full Text] [Related]
15. [Effects of vaccination in urinary infections caused by Escherichia coli in rats].
Mathieu D; Jacques L; Auer J; Bizzini B
Biomed Pharmacother; 1987; 41(8):442-5. PubMed ID: 3330459
[TBL] [Abstract][Full Text] [Related]
16. Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis.
Li X; Lockatell CV; Johnson DE; Lane MC; Warren JW; Mobley HL
Infect Immun; 2004 Jan; 72(1):66-75. PubMed ID: 14688082
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effect of MPL and delivery route on immunogenicity and protectivity of different formulations of FimH and MrpH from uropathogenic Escherichia coli and Proteus mirabilis in a UTI mouse model.
Habibi M; Asadi Karam MR; Bouzari S
Int Immunopharmacol; 2015 Sep; 28(1):70-8. PubMed ID: 26033493
[TBL] [Abstract][Full Text] [Related]
18. Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.
Luiz WB; Rodrigues JF; Crabb JH; Savarino SJ; Ferreira LC
Infect Immun; 2015 Dec; 83(12):4555-64. PubMed ID: 26371126
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with purified Dr Fimbriae reduces mortality associated with chronic urinary tract infection due to Escherichia coli bearing Dr adhesin.
Goluszko P; Goluszko E; Nowicki B; Nowicki S; Popov V; Wang HQ
Infect Immun; 2005 Jan; 73(1):627-31. PubMed ID: 15618205
[TBL] [Abstract][Full Text] [Related]
20. Vaginal immunization of monkeys against urinary tract infection with a multi-strain vaccine.
Uehling DT; Hopkins WJ; James LJ; Balish E
J Urol; 1994 Jan; 151(1):214-6. PubMed ID: 8254817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
